Effect of the selective 5-HT2A receptor antagonist EMD-281,014 on l-DOPA-induced abnormal involuntary movements in the 6-OHDA-lesioned rat
出版年份 2018 全文链接
标题
Effect of the selective 5-HT2A receptor antagonist EMD-281,014 on l-DOPA-induced abnormal involuntary movements in the 6-OHDA-lesioned rat
作者
关键词
-
出版物
EXPERIMENTAL BRAIN RESEARCH
Volume -, Issue -, Pages -
出版商
Springer Nature America, Inc
发表日期
2018-10-08
DOI
10.1007/s00221-018-5390-4
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Development of a selective and sensitive high-performance liquid chromatography-tandem mass spectrometry assay to support pharmacokinetic studies of LY-487,379 in rat and marmoset
- (2018) Fleur Gaudette et al. JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES
- The highly selective 5-HT 2A antagonist EMD-281,014 reduces dyskinesia and psychosis in the l -DOPA-treated parkinsonian marmoset
- (2018) Adjia Hamadjida et al. NEUROPHARMACOLOGY
- Development and validation of a high-performance liquid chromatography-tandem mass spectrometry method to quantify LY‐354,740 in rat and marmoset plasma
- (2017) Fleur Gaudette et al. JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES
- L-745,870 reduces the expression of abnormal involuntary movements in the 6-OHDA-lesioned rat
- (2015) Philippe Huot et al. BEHAVIOURAL PHARMACOLOGY
- The modern pre-levodopa era of Parkinson's disease: insights into motor complications from sub-Saharan Africa
- (2014) R. Cilia et al. BRAIN
- Pharmacological Treatment of Parkinson Disease
- (2014) Barbara S. Connolly et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Long-term effectiveness of dopamine agonists and monoamine oxidase B inhibitors compared with levodopa as initial treatment for Parkinson's disease (PD MED): a large, open-label, pragmatic randomised trial
- (2014) PD MED Collaborative Group LANCET
- Vascular endothelial growth factor is upregulated by l-dopa in the parkinsonian brain: implications for the development of dyskinesia
- (2011) K. Elisabet Ohlin et al. BRAIN
- Brain 5-HT2A receptors in MPTP monkeys and levodopa-induced dyskinesias
- (2011) Golnasim Riahi et al. EUROPEAN JOURNAL OF NEUROSCIENCE
- Characterization of 3,4-Methylenedioxymethamphetamine (MDMA) Enantiomers In Vitro and in the MPTP-Lesioned Primate: R-MDMA Reduces Severity of Dyskinesia, Whereas S-MDMA Extends Duration of ON-Time
- (2011) P. Huot et al. JOURNAL OF NEUROSCIENCE
- PKSolver: An add-in program for pharmacokinetic and pharmacodynamic data analysis in Microsoft Excel
- (2010) Yong Zhang et al. COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE
- 5-HT2A receptor levels increase in MPTP-lesioned macaques treated chronically with L-DOPA
- (2010) Philippe Huot et al. NEUROBIOLOGY OF AGING
- Serotonergic neurons mediate ectopic release of dopamine induced by l-DOPA in a rat model of Parkinson's disease
- (2010) Sylvia Navailles et al. NEUROBIOLOGY OF DISEASE
- Synthesis and in vitro affinities of various MDL 100907 derivatives as potential 18F-radioligands for 5-HT2A receptor imaging with PET
- (2009) Matthias M. Herth et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Contribution of the striatum to the effects of 5-HT1A receptor stimulation in L-DOPA-treated hemiparkinsonian rats
- (2009) Christopher Bishop et al. JOURNAL OF NEUROSCIENCE RESEARCH
- Alterations in 5-HT2Areceptor binding in various brain regions among 6-hydroxydopamine-induced Parkinsonian rats
- (2009) Yun Li et al. SYNAPSE
- Placebo influences on dyskinesia in Parkinson's disease
- (2008) Christopher G. Goetz et al. MOVEMENT DISORDERS
- Molecular mechanisms of L-DOPA-induced dyskinesia
- (2008) Peter Jenner NATURE REVIEWS NEUROSCIENCE
- A 5-HT2A receptor inverse agonist, ACP-103, reduces tremor in a rat model and levodopa-induced dyskinesias in a monkey model
- (2008) K VANOVER et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started